The CTLA-4 c.-1577 AA genotype was more common in patients than in controls; individuals with this genotype were at a 1.60 times greater risk of presenting CM than individuals with the GG or GA genotypes. This evidence concerns the gene CTLA4 and cutaneous mastocytosis.